Medications ·

Antidepressants: Same Use, Different Medicines

Not marked readNot yet practiced

Estimated study time. Take the time you need.

Introduction

Five common antidepressants can all appear on prescriptions for depression. They are still not the same medicine. Each has its own active ingredient, brand associations, class, other uses, dosage forms and warnings. A pharmacy technician's job is to recognize those differences and make sure none of them get lost between the prescription, the computer entry, the shelf and the pharmacist.

This lesson teaches you to tell these five medicines apart and to notice the details that must travel with each one.

What you will be able to do

Match bupropion, duloxetine, escitalopram, fluoxetine and trazodone to their brand associations, class labels and representative uses.
Explain why two medicines that both treat depression are not interchangeable.
Spot a release-form or warning detail that must not be dropped when work is handed from one person to another.

Before you start: You only need everyday reading. All terms are defined here. If you want more practice reading a full medicine identity, see Read a medicine identity before learning a name.

A medicine's identity has layers

When you see a medicine, you are seeing several facts stacked together. Each answers a different question.

Generic name answers: What is the active ingredient? Example: fluoxetine.
Brand name answers: What name has a manufacturer sold this under? Example: Prozac.
Class answers: Which group is it filed under? Example: selective serotonin reuptake inhibitor (SSRI).
Indication answers: What is it used to treat? Example: depression.
Dosage form and release type answer: What physical product is it, and how does it release the medicine? Example: delayed-release capsule.

A release type describes how the medicine is let out after it is swallowed. You will see these on the antidepressants in this lesson:

Sustained-release (SR) and extended-release (XL or ER): long-acting forms that release medicine over a longer time than the regular tablet.
Delayed-release (DR): holds the medicine back until it reaches the intestine instead of releasing it in the stomach.

Here is how the layers fit together. A label reads "Wellbutrin XL." The ingredient is bupropion. The brand is Wellbutrin. The "XL" tells you it is the extended-release product. All of these facts are part of what the patient was prescribed. Losing the "XL" turns it into a different product, even though the ingredient stays the same.

Question 1

A prescription reads "duloxetine delayed-release capsule." Which part names the active ingredient, and which part names the dosage form and release type? Why does keeping the second part matter?

Show answer and explanation

"Duloxetine" is the active ingredient. "Delayed-release capsule" is the dosage form and release type. The second part matters because it describes a specific physical product with its own handling rules. For duloxetine, the delayed-release capsule releases medicine in the intestine to protect it from stomach acid. That design is part of what was ordered. Knowing the ingredient alone does not tell you which product to choose.

Meet the five medicines

Learn each medicine as a complete identity: ingredient, brand association, class and uses. A brand association is a brand name linked to the ingredient. It is not a promise that the brand is sold today. MedlinePlus marks several of the brands below as no longer on the market, but they may still appear as exam associations or in older records.

Two SSRIs: fluoxetine and escitalopram

SSRI stands for selective serotonin reuptake inhibitor. In plain English, the class is defined by its focus on serotonin, a natural brain chemical. MedlinePlus describes these medicines as increasing the amount of serotonin.

Fluoxetine is associated with Prozac. Other brands linked to it, such as Prozac Weekly and Sarafem, are marked as no longer on the market. Its uses include depression, obsessive-compulsive disorder, some eating disorders, panic attacks and premenstrual dysphoric disorder. Fluoxetine comes in more forms than the other four medicines here: capsule, tablet, liquid solution and a delayed-release capsule taken once a week. Symbyax is a combination product that contains fluoxetine together with olanzapine.

Escitalopram is associated with Lexapro. It is used for depression and generalized anxiety disorder (GAD, ongoing excessive worry and tension). It comes as a tablet and a liquid solution and is taken once a day.

Both are SSRIs and both treat depression. Their other uses and available forms are different.

One SNRI: duloxetine

SNRI stands for serotonin and norepinephrine reuptake inhibitor. The name adds a second brain chemical, norepinephrine. That added word is what separates this class from the SSRIs.

Duloxetine is associated with Cymbalta and Drizalma Sprinkle. It is used for depression and GAD. It is also used for pain: nerve pain from diabetes, fibromyalgia, and ongoing bone or muscle pain. The source lists it as a delayed-release capsule.

Bupropion: a broader class label

Bupropion is associated with Wellbutrin, Wellbutrin SR, Wellbutrin XL and Aplenzin. Zyban and some other bupropion brands are marked as no longer on the market. MedlinePlus simply calls it an antidepressant. It does not file bupropion under SSRI or SNRI.

Bupropion is used for depression and seasonal affective disorder (depression that returns at the same time each year). It is also used to help people stop smoking. It comes as a regular tablet, a sustained-release tablet and an extended-release tablet. Depending on the form, it is taken 1 to 4 times a day.

Contrave and Auvelity are combination products. Each contains bupropion plus a second ingredient: naltrexone in Contrave and dextromethorphan in Auvelity. A combination product is not the same as plain bupropion.

Trazodone: a different serotonin class

Trazodone is linked to the brands Desyrel, Oleptro and Trialodine. All three are marked as no longer on the market. It is used to treat depression, and it is also sometimes used for other conditions, including insomnia. Its class is serotonin modulators.

MedlinePlus describes both trazodone and the SSRIs as increasing serotonin. They still sit in different classes. Two medicines that affect the same brain chemical are not automatically in the same class.

Quick reference

Generic name	Brand associations (some no longer marketed)	Class as labeled in source	Representative uses
Fluoxetine	Prozac	SSRI	Depression, OCD, panic attacks, PMDD
Escitalopram	Lexapro	SSRI	Depression, GAD
Duloxetine	Cymbalta, Drizalma Sprinkle	SNRI	Depression, GAD, diabetic nerve pain, fibromyalgia
Bupropion	Wellbutrin (SR, XL), Aplenzin	Antidepressant	Depression, seasonal affective disorder, quitting smoking
Trazodone	Desyrel	Serotonin modulator	Depression

Question 2

A coworker says, "Cymbalta and Lexapro are basically the same because they're both for anxiety and depression." Name each generic, give each class, and name one use that one has and the other does not.

Show answer and explanation

Cymbalta is duloxetine, an SNRI. Lexapro is escitalopram, an SSRI. Duloxetine is also used for pain, such as diabetic nerve pain and fibromyalgia. Escitalopram's source does not list those uses. Sharing two uses does not make them the same. They have different ingredients and different classes, and only one has pain uses. The tempting mistake is to treat overlapping uses as proof of matching identities.

Why a shared use does not make medicines interchangeable

All five medicines can be used to treat depression, but as you saw above, each also has other uses. Knowing which medicine was prescribed, or that it shares a use with another medicine, does not tell you this patient's diagnosis. It also does not tell you which ingredient, product or instructions the patient needs. Three things differ even when the indication is the same.

1. The rest of the identity differs. As you saw above, the ingredient, class, other uses and forms all change from one medicine to the next.

2. The details that come with each product differ. Look at one detail every source mentions: MAO inhibitors, a group of medicines that includes phenelzine, linezolid and methylene blue. Each source tells patients to report recent MAO inhibitor use. The required wait after stopping the antidepressant before starting an MAO inhibitor differs:

Duloxetine: at least 5 days.
Fluoxetine: at least 5 weeks.
Trazodone: at least 14 days.

The escitalopram and bupropion sources in this lesson give no such after-stopping wait. They only cover MAO inhibitors taken within the past two weeks. Notice the direction, too. "Wait after stopping fluoxetine before starting an MAO inhibitor" is a one-way instruction. You cannot flip it or apply it to a different medicine. Applying these timing rules is the pharmacist's and prescriber's job. Your job is to recognize that the rules differ. More detail is in Duplication, interactions and contraindications.

3. Swapping one medicine for another is a clinical decision. Replacing a medicine with a different one used for the same condition is called therapeutic substitution. The PTCE content outline lists therapeutic substitution among the issues that require pharmacist intervention. When a patient, coworker or shortage raises the question "Can we use this one instead?", you recognize it and bring it to the pharmacist. You do not answer it yourself. Separate laws and policies, which can differ by state, govern when one product may replace another. This lesson does not teach those rules.

Worked example

A prescription is written for escitalopram. The shelf is out. A coworker suggests filling fluoxetine instead, because both are SSRIs for depression.

Compare identities. The ingredients are different. The forms are different: fluoxetine has a once-weekly delayed-release capsule, and escitalopram is taken once daily. The listed uses are different. The MAO-inhibitor timing detail is different.
Name the type of decision. Choosing a different medicine is therapeutic substitution. That is a pharmacist and prescriber issue.
Act. Tell the pharmacist that escitalopram is out of stock. Do not fill fluoxetine.

Change one fact. Now the prescription is for fluoxetine capsules, and only fluoxetine tablets are on the shelf. The ingredient now matches. The product is still different. The question has changed from "which medicine?" to "which form?", but it is still not yours to decide. Bring it to the pharmacist.

Question 3

A patient asks, "My new prescription is trazodone, but my sister takes Prozac for depression. Can I just get Prozac? Same thing, right?" What do you recognize, and what do you do?

Show answer and explanation

Prozac is fluoxetine, an SSRI. Trazodone is a serotonin modulator. Both treat depression, but they have different ingredients, classes and listed details. For example, the required wait before starting an MAO inhibitor after stopping each one is different. The patient is asking about therapeutic substitution, which is a pharmacist intervention issue. Do not agree or disagree with the clinical idea. Tell the patient the pharmacist will help, and bring the pharmacist in. Sharing a use is not permission to swap.

Release forms and handling details travel with the product

The same ingredient can come in products that behave differently. The difference changes how often the medicine is taken and how it can be handled.

Bupropion. The regular tablet, the SR tablet and the XL tablet are taken different numbers of times per day. The SR and XL tablets must be swallowed whole. They must not be split, chewed or crushed. If you drop "XL" from a record, you have changed the product.
Fluoxetine. The regular capsule, tablet and liquid are taken once or twice a day. The delayed-release capsule is taken once a week and must be swallowed whole. Mixing up the weekly and daily products changes the dosing schedule completely.
Duloxetine. The delayed-release capsule is swallowed whole. One product is an exception: Drizalma Sprinkle capsules may be opened and sprinkled over applesauce or given through a nasogastric tube (a feeding tube through the nose). That permission belongs to Drizalma Sprinkle only. It does not extend to other duloxetine products.
Trazodone. The tablet may be swallowed whole or broken in half on the score mark (the line pressed into the tablet). This is taken with a meal or light snack.

The pattern: a handling rule belongs to a specific product, not to the ingredient or the class. "May be split" is true for trazodone tablets and false for bupropion SR. "May be opened" is true for Drizalma Sprinkle and not stated for other duloxetine capsules. For more on dosage forms, see Forms, routes and special administration.

Question 4

A technician enters a prescription for "bupropion XL" but selects the regular bupropion tablet because "it's the same drug." What has gone wrong, and why does it matter?

Show answer and explanation

The ingredient matches, but the formulation does not. XL is an extended-release, long-acting tablet. The regular tablet is a different product and is taken a different number of times per day. Picking it changes what the patient actually receives. Same ingredient does not mean same formulation. Correct the selection, or bring the question to the pharmacist before the work moves forward.

Warnings that must survive a handoff

A handoff is any point where work or information passes to another person. Examples include intake to data entry, a technician to the pharmacist, or one shift to the next. Details get lost at these points. For antidepressants, two kinds of warnings matter most.

A shared warning: suicidal thoughts. All five MedlinePlus pages carry the same important warning. Medicines like these may increase the risk of suicidal thoughts and actions in children, teenagers and young adults. In the pooled study data in the trazodone prescribing label, the young-adult group runs from age 18 through 24. The risk may be higher in the first few months of treatment and when the dose is increased. The label also says to closely monitor all patients taking antidepressants, at any age, for worsening and for suicidal thoughts and behaviors, especially early in treatment and whenever the dose is changed. Each page says the patient receives a Medication Guide, an FDA-required patient information sheet. The bupropion page says it is given at the start of treatment and with each refill.

If a patient says something that suggests thoughts of suicide or self-harm, tell the pharmacist immediately. Do not wait until the transaction is finished. NIMH advises getting help as soon as possible when warning signs appear. If someone says they are going to kill themselves, do not leave them alone. Call 911 if there is an immediate life-threatening situation. The 988 Suicide & Crisis Lifeline (call or text 988) offers 24-hour support. Also follow your pharmacy's emergency procedure.

Lists of warning signs are examples. They are not a complete checklist. If a patient doesn't mention a plan or a listed symptom, that does not mean the situation is not urgent. NIMH says all talk of suicide should be taken seriously.

Product-specific warnings. Some warnings belong to just one medicine. Trazodone can cause priapism, a prolonged erection. The trazodone prescribing label describes reported priapism cases as painful erections lasting more than 6 hours, but that describes the cases, not when to act. The label says a man with an erection lasting more than 4 hours, whether painful or not, should stop the drug and seek emergency medical attention immediately. Do not suggest waiting until 6 hours. For bupropion, MedlinePlus says that patients with a history of seizures or certain eating disorders will probably be told by their doctor not to take it. Do not carry these warnings over to the other four medicines.

A reported symptom is not proof of cause. When a patient reports a symptom, write down what the patient said and pass it to the pharmacist. A symptom listed on a drug's information page shows that the drug can cause it. It does not prove the drug caused this patient's symptom. Deciding that is clinical work. See Recognize when the pharmacist must intervene.

Question 5

A note left for the next shift reads: "Refill ready: duloxetine. Pt asked whether it's OK to open caps into applesauce — told her yes, same as the sprinkle kind." The record shows a duloxetine delayed-release capsule that is not Drizalma Sprinkle. What is wrong?

Show answer and explanation

The note applied a product-specific permission to the wrong product. MedlinePlus says Drizalma Sprinkle capsules may be opened and sprinkled on applesauce. It says duloxetine delayed-release capsules in general should be swallowed whole. The patient's question was about administration, so it should have gone to the pharmacist. The next shift should alert the pharmacist so the patient can be given correct information.

Independent practice

Question 6

Match each brand association to its generic name and class: Lexapro, Wellbutrin XL, Desyrel, Prozac, Cymbalta.

Show answer and explanation

Lexapro → escitalopram, SSRI.
Wellbutrin XL → bupropion (extended-release tablet), labeled simply as an antidepressant.
Desyrel → trazodone, serotonin modulator.
Prozac → fluoxetine, SSRI.
Cymbalta → duloxetine, SNRI.

If you grouped trazodone with the SSRIs because it raises serotonin, look again at the class labels. The source files trazodone under a different class. A shared effect on serotonin does not make a shared class.

Question 7

This is a fictional case, and every assumption is given. The prescription is for fluoxetine delayed-release capsules, one capsule once a week, quantity 4. (a) What is the days supply? (b) The entry screen shows the regular fluoxetine capsule was selected. Does the correct days supply make the entry acceptable?

Show answer and explanation

(a) 4 capsules × 7 days per capsule = 28 days.

(b) No. The math is correct, but the product is wrong. Regular capsules are taken once or twice a day. The delayed-release capsule is the once-weekly product. A correct calculation on the wrong product is still a wrong fill. Correct arithmetic does not authorize dispensing. Fix the product selection or flag it for the pharmacist.

Question 8

Two medicines treat depression. One is a trazodone tablet, and the other is a bupropion SR tablet. A handoff note for both says "OK to split." Which part of the note is wrong, and what rule explains the mistake?

Show answer and explanation

"OK to split" is supported for trazodone, and only on the score mark. It is wrong for bupropion SR, which must be swallowed whole and never split, chewed or crushed. The rule: handling instructions belong to a specific product, not to everything with the same use. A shared indication tells you nothing about handling.

Question 9

This is a fictional case. A patient picking up escitalopram says, quietly, "I don't really see the point of any of this anymore." They say nothing else. What should you do?

Show answer and explanation

Treat it as a warning sign and tell the pharmacist immediately, before finishing the transaction. NIMH lists talk of hopelessness or having no reason to live among warning signs, and says to get help as soon as possible. The patient did not mention a plan, but that does not lower the urgency, because warning-sign lists are not complete checklists. Stay with the patient while you get the pharmacist. If the situation appears immediately life-threatening, call 911 and follow your pharmacy's emergency procedure. Do not try to judge the patient's risk yourself.

Question 10

This is a fictional case. A patient on duloxetine says, "I've felt dizzy when I stand up ever since I started this. It's the pill, right?" How do you respond, and why?

Show answer and explanation

Write down what the patient reported and bring it to the pharmacist. MedlinePlus does list dizziness when getting up quickly as a possible duloxetine effect. A listed effect is not proof that the drug caused this patient's dizziness, and deciding the cause is clinical work. Don't confirm it and don't dismiss it. Pass the report along accurately.

What to remember

Identity has layers. Ingredient, brand, class, indication and release form each answer a different question. Keep all of them.
The five medicines: fluoxetine (Prozac) and escitalopram (Lexapro) are SSRIs. Duloxetine (Cymbalta) is an SNRI with pain uses. Bupropion (Wellbutrin) is labeled simply as an antidepressant and is also used to help people quit smoking. Trazodone (Desyrel) is a serotonin modulator.
A shared use is not a shared identity. Choosing a different medicine is therapeutic substitution, which is a pharmacist issue.
Release forms are part of the product. SR, XL and DR change how often a medicine is taken and how it may be handled. Splitting and opening permissions belong to specific products only.
Warnings must survive handoffs. Bring any talk of suicide or self-harm to the pharmacist immediately, and call 911 for immediate danger. Record reported symptoms and route them without deciding what caused them.